We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
- Authors
Hadziyannis, Stephanos J; Sette, Hoel, Jr; Morgan, Timothy R; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry, Jr; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; Pockros, Paul J; Lin, Amy; Ackrill, Andrew M; PEGASYS International Study Group
- Abstract
Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
- Publication
Annals of internal medicine, 2004, Vol 140, Issue 5, p346
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/0003-4819-140-5-200403020-00010